AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


The Lab's Role in Prenatal Screening: Now and the Future - CD

The Lab's Role in Prenatal Screening
  • Copyright: 2013
  • Speaker: Chris Robinson

Price: $119.00

Member Price: $99.00

This webcast originally aired as a live webinar sponsored by AACC on November 26, 2013.

The technologies used to screen pregnant women to determine if their unborn children have chromosomal abnormalities are advancing at a rapid pace, and patients are demanding that physicians provide them with state-of-the-art prenatal testing. During this program, Dr. Chris Robinson discusses best practices for using first trimester biochemical screening markers in conjunction with imaging technologies and state-of-the-art strategies for second trimester screening. He also explains why microarrays are playing an increasing role in prenatal testing and what emerging "non-invasive" screening technologies (such as the measurement of fetal DNA in maternal circulation) have to offer.